News & Perspective

Apr 22, 2010

Apr 22, 2010

International group renews push to fight avian, pandemic flu

(CIDRAP News) – An international avian and pandemic flu meeting in Hanoi concluded yesterday, with health ministers and top officials from more than 70 countries agreeing on a set of strategies for responding to future disease threats.

Oct 27, 2008

Oct 27, 2008

Donors meeting nets funds for avian flu fight

(CIDRAP News) – A group of international donors who met yesterday in the final session of an avian influenza conference in Sharm el-Sheikh, Egypt, pledged more support for avian and pandemic flu preparedness and prevention, led by $320 million from the United States.

Apr 03, 2008

Apr 03, 2008

China approves its first H5N1 vaccine

(CIDRAP News) – China's State Food and Drug Administration (SFDA) yesterday approved the country's first prepandemic H5N1 influenza vaccine, an inactivated whole-virus product made by Sinovac, a Beijing-based biotechnology company.

Jan 24, 2008

Jan 24, 2008

FAO: Spate of H5N1 outbreaks warrants stronger controls

(CIDRAP News) – Outbreaks of H5N1 avian influenza in 15 countries since December 2007 are a potent reminder that the virus is still a global threat, the United Nations Food and Agriculture Organization (FAO) warned today, as officials in Thailand announced they found the disease in poultry again after a 6-month lapse.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 29, 2007

Oct 29, 2007

THE PANDEMIC VACCINE PUZZLE Part 3: H5N1 poses major immunologic challenges

Editor's note: This is the third in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

May 09, 2007

May 09, 2007

EU approves Novartis's 'mock-up' pandemic vaccine

(CIDRAP News) – The European Union (EU) this week approved a "mock-up" influenza vaccine made by Novartis to permit a faster start on vaccine production in the event of a flu pandemic.

Pages

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»